Tegsedi logo
Tegsedi: the first & only subcutaneous at-home
treatment to silence the TTR gene in hATTR1–3
Tegsedi: the first & only subcutaneous at-home treatment to silence the TTR gene in hATTR1–3

Resources for you and your patients

You can download the documents directly to your computer/device or if you would prefer hard copies please contact us on +44 (0) 330 1590 174.

  • RESOURCES FOR YOU
  • RESOURCES FOR YOUR PATIENTS
Akcea Connect information for HCPs thumbnail
AKCEA CONNECT Service -Information for HCPs

Date added:
August 2020

File Size: 3.1 mb

Tegsedi prescribing guide thumbnail
Tegsedi Prescribing Guide
 

Date added:
August 2020

File Size: 1.9 mb

Patrick's Story
Living with hATTR
Patrick’s story

Date added: August 2020

Length: 04:11

Patrick's story: Life on Tegsedi
Life on Tegsedi
Patrick’s story

Date added: August 2020

Length: 02:19

Stuart's story
Living with hATTR
Stuart & Elspeth’s story

Date added: August 2020

Length: 04:15

introduction to hATTR thumbnail
Introduction to hATTR
 

Date added:
August 2020

File Size: 1.3 mb

Akcea Connect Service thumbnail
Akcea Connect Service – Information for patients

Date added:
August 2020

File Size: 3.1 mb

About Tegsedi thumbnail
About Tegsedi
 

Date added:
August 2020

File Size: 1.3 mb

Tegsedi Injection Guide thumbnail
Tegsedi Injection Guide
 

Date added:
August 2020

File Size: 696 kb

Tegsedi Injection Mat thumbnail

Tegsedi Injection Mat  

Date added:
August 2020

File Size: 696 kb

Tegsedi Treatment Tracker thumbnail

My Tegsedi Treatment Tracker

Date added:
August 2020

File Size: 1.4 mb

Connections newsletter June thumbnail

Connections Newsletter June 2020 edition

Date added:
August 2020

File Size: 1.4 mb

Patrick's story: Life on Tegsedi
Life on Tegsedi
Patrick’s story

Date added: August 2020

Length: 02:19

Patrick's Story
Living with hATTR
Patrick’s story

Date added: August 2020

Length: 04:11

Stuart's story
Living with hATTR
Stuart & Elspeth’s story

Date added: August 2020

Length: 04:12

References:

1. Tegsedi SmPC, October 2019.
2. Benson MD, Waddington-Cruz M, Berk JL, et al. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. N Engl J Med. 2018;379(1):22−31.
3. Brannagan TH et al. European Journal of Neurology 2020, 0:1-8. Published online 28th April 2020.

hATTR, Hereditary transthyretin amyloidosis; TTR, transthyretin.
Akcea Connect Logo

You are about to leave the Akcea Connect website

Akcea Connect is not responsible for any information, statements, or other content you may encounter on third-party websites.